Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;115:e404
doi: 10.1161/CIRCULATIONAHA.106.677708
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shroff, G. R.
Right arrow Articles by Orlandi, Q. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shroff, G. R.
Right arrow Articles by Orlandi, Q. G.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow CV surgery: other

(Circulation. 2007;115:e404.)
© 2007 American Heart Association, Inc.


Correspondence

Letter by Shroff and Orlandi Regarding Article, "Randomized Trial of Atorvastatin for Reduction of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery: Results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) Study"

Gautam R. Shroff, MD; Quirino G. Orlandi, MD

University of Minnesota,, Minneapolis Heart Institute, Minneapolis, Minn.

To the Editor:

We read with great interest the study by Patti and colleagues1 that suggests a beneficial effect of atorvastatin in preventing postoperative atrial fibrillation in cardiac surgery patients.

The placebo arm in this study had fewer patients on ß-blockers (60% versus 72%, P=0.08), more patients with left atrial enlargement (46% versus 36%, P=0.16), more patients with mitral valve disease (7% versus 2%, P=0.10) and more patients undergoing valve surgery (25% versus 16%). All these variables are known to have a strong association with atrial fibrillation.2 Although these individual differences were not statistically significant, the combination of these variables likely contributed to the magnitude of the treatment effect.

It would be helpful for clinicians to know the incremental benefit of atorvastatin in patients already receiving ß-blocker therapy. We also invite the authors to comment on the difference in the clinical outcome after adjusting for the magnitude of left atrial enlargement. Recent data demonstrate that left atrial volume is a strong predictor of atrial fibrillation after cardiac surgery.3 Therefore, it would be relevant to know how left atrial enlargement was measured in the study.

Lastly, 75% patients in the placebo arm of this study and 83% patients in the atorvastatin arm underwent elective coronary bypass surgery. In modern cardiology practice, it would be unusual for patients with established coronary disease to undergo elective bypass surgery without any prior statin therapy. This study, however, highlights the potential benefit of even a short course of statin therapy prior to surgery in preventing atrial fibrillation.


*    Acknowledgments
 
Disclosures

None.


*    References
up arrowTop
*References
 

  1. Patti G, Chello M, Candura D, Pasceri V, D’Ambrosio A, Covino E, Di Sciascio G. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006; 114: 1455–1461.[Abstract/Free Full Text]
  2. Hogue CW Jr., Creswell LL, Gutterman DD, Fleisher LA; American College of Chest Physicians. Epidemiology, mechanisms, and risks: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest. 2005; 128 (2 Suppl): 9S–16S.[CrossRef][Medline] [Order article via Infotrieve]
  3. Osranek M, Fatema K, Qaddoura F, Al-Saileek A, Barnes ME, Bailey KR, Gersh BJ, Tsang TS, Zehr KJ, Seward JB. Left atrial volume predicts the risk of atrial fibrillation after cardiac surgery: a prospective study. J Am Coll Cardiol. 2006; 48: 779—786.[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shroff, G. R.
Right arrow Articles by Orlandi, Q. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shroff, G. R.
Right arrow Articles by Orlandi, Q. G.
Related Collections
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow CV surgery: other